From the1Clinical Pharmacy Research Group (CLIP)–Louvain Drug Research Institute (LDRI), UCLouvain
2Fonds de la Recherche Scientifique—FNRS
3Institute of Neuroscience (IoNS), UCLouvain
4Psychiatry Department, Cliniques Universitaires Saint-Luc, Brussels
5Hôpital Psychiatrique du Beau Vallon, Namur
6Integrated PharmacoMetrics, PharmacoGenomics and PharmacoKinetics (PMGK)–Louvain Drug Research Institute (LDRI), UCLouvain
7Louvain Centre for Toxicology and Applied Pharmacology (LTAP)–Institut de Recherche Expérimentale et Clinique (IREC), UCLouvain
8Pharmacy Department, Cliniques Universitaires Saint-Luc, Brussels, Belgium.
Received October 5, 2022; accepted after revision January 2, 2023.
Address correspondence to: Juliette Lagreula, MPharm, MSc, Clinical Pharmacy Research Group (CLIP)–Louvain Drug Research Institute (LDRI), Université Catholique de Louvain, Avenue Mounier 72, 1200 Brussels, Belgium (e-mail: [email protected]).
J.L. and M.F. equally contributed to this work.
留言 (0)